Drug Profile
ZO Y49
Alternative Names: ZO-Y49Latest Information Update: 24 May 2016
Price :
$50
*
At a glance
- Originator Zeria
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Female genital diseases
Most Recent Events
- 24 May 2016 No development reported - Phase-III for Gynaecological disorder in Japan (PO)